Author:
Gritskevich A. A.,Medvedev V. L.,Teplov A. A.,Mishugin S. V.,Shakhnovich E. B.,Pyanikin S. S.,Rusakov I. G.
Publisher
Media Sphere Publishing Group
Reference64 articles.
1. Shahinian V.B., Kuo Y.F., Gilbert S.M. Reimbursement policy and androgen-deprivation therapy for prostate cancer. N. Engl. J. Med. 2010; 363: 1822—32.
2. Pagliarulo V., Bracarda S., Eisenberger M.A., Mottet N., Schrӧder F.H. Contemporary role of androgen deprivation therapy for prostate cancer. Eur. Urol. 2012; 61: 11—25.
3. Arnold M., Karim-Kos H.E., Coebergh J.W. et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. Eur. J. Cancer. 2013; Oct 8. pii: S0959-8049 (13)00842
4. De Angelis R., Sant M., Coleman M.P. et al.; EUROCARE-5 Working Group. Cancer survival in Europe 1999—2007 by country and age: results of EUROCARE-5 — a population-based study. Lancet Oncol. 2014; 15 (1): 23—34.
5. Cancer incidence in Sweden 2004. The National Board of Health and Welfare: Stockholm.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献